Thomas Gremmel

Associate Professor

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Immunology Immunology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Thomas Gremmel is an Associate Professor at Landesklinikum Wiener Neustadt, Austria. His research primarily focuses on cardiovascular diseases, including antiplatelet therapies, thrombotic drivers in viral infections, and platelet activation markers. Recent publications include systematic reviews and meta-analyses on medication efficacy and the physiological mechanisms underlying cardiovascular events. He is actively engaged in advancing the understanding of microvascular thrombosis and its implications in severe health conditions such as COVID-19.

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Dominik Wiedemann

Medical University of Vienna

AUSTRIA

View details

Thomas Perkmann

Medical University of Vienna

AUSTRIA

View details

Christoph Neumayer

Medical University of Vienna

AUSTRIA

View details

Bernd Jilma

Full Professor

Medical University of Vienna

AUSTRIA

View details

Patricia P. Wadowski

Medical University of Vienna

AUSTRIA

View details

Franziska Wittmann

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas Gremmel

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Antiplatelet therapy with clopidogrel versus aspirin in atherosclerotic cardiovascular disease: a systematic review and meta-analysis

Reply: Are we comparing apples with oranges?

Cardiovascular events in patients treated with bempedoic acid vs. placebo: systematic review and meta-analysis

Toll-like Receptors as Pro-Thrombotic Drivers in Viral Infections: A Narrative Review

Microvascular Thrombosis as a Critical Factor in Severe COVID-19

Growth Differentiation Factor-15 Correlates Inversely with Protease-Activated Receptor-1-Mediated Platelet Reactivity in Patients with Left Ventricular Assist Devices

Platelet-to-Lymphocyte Ratio as Marker of Platelet Activation in Patients on Potent P2Y12 Inhibitors

Sex-specific platelet activation through protease-activated receptor-1 in patients undergoing cardiac catheterization

Comparison of Light Transmission Aggregometry With Impedance Aggregometry in Patients on Potent P2Y12 Inhibitors

Activation of platelet-rich plasma by pulse electric fields: Voltage, pulse width and calcium concentration can be used to control and tune the release of growth factors, serotonin and hemoglobin

Decreased Platelet Inhibition by Thienopyridines in Hyperuricemia

Mean Corpuscular Volume Predicts Adverse Outcomes Following Peripheral Angioplasty With Stenting and Is Associated With On-Treatment Platelet Reactivity

Collaborators (6)

Dominik Wiedemann

Thomas Perkmann

Christoph Neumayer

Bernd Jilma

Patricia P. Wadowski

Franziska Wittmann

Make your next move.